Egg Reserve
The question of whether hormonal contraception affects the female reproductive timeline is both complex and deeply relevant. Women today are having children later in life, but with advancing age comes a natural decline in fertility due to the depletion of the egg reserve, or ovarian reserve. A growing number of studies and medical observations are examining whether long-term use of the contraceptive pill influences this biological process.
Understanding the Ovarian Reserve and the Biological Clock
A woman is born with all the eggs she will ever have—around 2 million at birth, reduced from approximately 7 million during fetal development. By puberty, this number drops to roughly 500,000 eggs. Every menstrual cycle, 50 to 1,000 eggs die, leaving only a single egg to mature and be released during ovulation.
By the time a woman is 30 years old, her egg reserve falls to about 50,000, and by 40, it may drop to 9,000 or fewer. This natural decline is the root of the metaphorical “ticking biological clock.” Once the ovarian reserve is exhausted, menopause begins, marking the end of fertility.
The Hidden Risk of the Pill
While the pill does not directly damage eggs, it masks your fertility status, meaning you only know the reality of your ovarian reserve after you stop. This can lead to delays in diagnosing fertility challenges, especially for women who start trying for children later in life. Understanding your ovarian reserve early and planning accordingly is essential to avoid unpleasant surprises.
FAQs
1) Landersoe SK, Petersen KB, Vassard D, et al. Concerns on future fertility among users and past-users of combined oral contraceptives: a questionnaire survey. Eur J Contracept Reprod Health Care. 2019;24(5):347-355. doi:10.1080/13625187.2019.1639659
2) Nawroth F, Ludwig M, Gnoth C, et al.: Bewertung von ovarieller Reserve und Fertilität mit steigendem Lebensalter Gemeinsame Stellungnahme der Deutschen Gesellschaft für Gynäkologische Endokrinologie und Fortpflanzungsmedizin (DGGEF) e.V., der Deutschen Gesellschaft für Reproduk- tionsmedizin (DGRM) e.V. und des Berufsverbandes der Frauenärzte (BVF) e.V. F.Der Frauenarzt 2013;54(7)682-688. https://www.green-ivf.de/templates/media/pdf/gnoth/2013_Ovarielle_Reserve_Frauenarzt.pdf
3) Ding N, Harlow SD, Randolph JF, et al. Associations of Perfluoroalkyl Substances with Incident Natural Menopause: The Study of Women's Health Across the Nation. J Clin Endocrinol Metab. 2020;105(9):e3169-e3182. doi:10.1210/clinem/dgaa303
4) Birch Petersen K, Hvidman HW, Forman JL, et al. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan. Hum Reprod. 2015;30(10):2364-2375. doi:10.1093/humrep/dev197
5) Kushnir VA, Barad DH, Gleicher N. Ovarian reserve screening before contraception?. Reprod Biomed Online. 2014;29(5):527-529. doi:10.1016/j.rbmo.2014.07.013
6) Landersoe SK, Larsen EC, Forman JL, et al. Ovarian reserve markers and endocrine profile during oral contraception: Is there a link between the degree of ovarian suppression and AMH? [published online ahead of print, 2020 May 2]. Gynecol Endocrinol. 2020;1-6.
7) Through Platelet-Rich Autologous Plasma (PRP)-a Chance to Have a Baby Without Donor Eggs, Improving the Life Quality of Women Suffering from Early Menopause Without Synthetic Hormonal Treatment [published online ahead of print, 2020 Jul 22]. Reprod Sci. 2020;10.1007/s43032-020-00266-8. doi:10.1007/s43032-020-00266-8